Meet Inspiring Speakers and Experts at our 3000+ Global Conference Series Events with over 1000+ Conferences, 1000+ Symposiums
and 1000+ Workshops on Medical, Pharma, Engineering, Science, Technology and Business.Explore and learn more about Conference Series : World's leading Event Organizer
As per available reports about 57 relevant Journals, 26 Conferences, 705 Workshops are presently dedicated exclusively to Oncogenomics and about 2504 Open Access articles are being published on Oncogenomics.
Oncogenomics is a relatively new sub-field of genomics that applies high throughput technologies to characterize genes associated with cancer. Oncogenomics is synonymous with "cancer genomics". Cancer is a genetic disease caused by accumulation of mutations to DNA leading to unrestrained cell proliferation and neoplasm formation. The goal of oncogenomics is to identify new oncogenes or tumor suppressor genes that may provide new insights into cancer diagnosis, predicting clinical outcome of cancers, and new targets for cancer therapies. The success of targeted cancer therapies such as Gleevec, Herceptin, and Avastin raised the hope for oncogenomics to elucidate new targets for cancer treatment.
OMICS International Organizes 1000+ Global Events Every Year across USA, Europe & Asia with support from 1000 more scientific societies and Publishes 700+ Open access journals which contains over 100000 eminent personalities, reputed scientists as editorial board and organizing committee members. The conference series website will provide you list and details about the conference organize worldwide.
Scope and Importance:
The completion of the Human Genome Project has greatly facilitated the field of oncogenomics and has increased the abilities of researchers to find cancer causing genes. In addition, the sequencing technologies now available for sequence generation and data analysis have been applied to the study of oncogenomics. With the amount of research conducted on cancer genomes and the accumulation of databases documenting the mutational changes, it has been predicted that the most important cancer-causing mutations, rearrangements, and altered expression levels will be catalogued and well characterized within the next decade. Cancer research may look either on the genomic level at DNA mutations, the epigenetic level at methylation or histone modification changes, the transcription level at altered levels of gene expression, or the protein level at altered levels of protein abundance and function in cancer cells. Oncogenomics focuses on the genomic, epigenomic, and transcript level alterations in cancer.
Market Analysis:
The American Cancer Society reported that among 1.5 million cases half a million die from the disease mostly of breast cancer, lung cancer, bladder cancer, leukemia. The expenditure on cancer care in 2010 was $125 billion and is estimated to reach $156 billion by 2020 in US.US occupies seventh place in breast cancer worldwide.
List of Best International Conferences
1. 9th Cancer Therapy Summit
November 02-04, 2015 Hyderabad, India
2. Cancer Diagnostics Conference & Expo
June 13-15, 2016 Rome, Italy.
3. 8th Cancer Therapy Conferences
November 03-05, 2015 Valencia, Spain
4. 12th Cancer Therapy Conferences
September 26-28, 2016 London, UK
5. 6th Cancer Therapy Congress
Baltimore, USA
6. 11th Asia-Pacific Oncologists Annual Meeting
July 11-13, 2016 Kuala Lumpur, Malaysia
7. 4th Integrative Biology Conference
July 18-20, 2016 Berlin, Germany
8. 2nd Synthetic Biology Conference
August 15-17, 2016 London, United Kingdom
9. Pancreatic and Colorectal Cancer Conference
March 29-30, 2016, Atlanta, USA
10. Prostate Cancer Conference
May 05-07, 2016, Chicago, USA
11. Genetic Counselling and Genomic Medicine Conference
August 11-12, 2016 Birmingham, UK
12. Molecular and Cancer Biomarkers Conference and Expo
September 15-17, 2016 Berlin, Germany
13. Clinical and Molecular Genetics Conference
November 28-30, 2016 Chicago, USA
14. 5th Cell and Gene Therapy Conference
May 19-21, 2016 San Antonio, USA
15. 2nd Transcriptomics Conference
August 18-20, 2016 Portland, Oregon USA
16. 6th Bioinformatics Conference
March 29-30, 2016 Valencia, Spain
17. 6th Proteomics Conference
March 31-Apr 2, 2016, Atlanta, USA
18. 5th Metabolomics Conference
May 16-18, 2016, Osaka, Japan
19. Structural Biology Conference
June 23-24, 2016, New Orleans, USA
20. European Cancer Congress, Vienna, Austria
21. 2015 Northeast Cancer Conference, Troy, NY
22. NCRI Cancer Conference, Liverpool
23. Advances in Breast Cancer Research, Bellevue, Washington
24. International Conference on Molecular Targets and Cancer Therapeutics, Boston, Massachusetts
25. New Horizons in Cancer Research Conference: Bringing Cancer Discoveries to Patients, Shanghai, P.R. China
26. Chromatin and Epigenetics in Cancer, Atlanta, Georgia
27. Advances in Ovarian Cancer Research: Exploiting Vulnerabilities, Orlando, Florida
28. World Cancer Congress, Paris, France
29. European Cancer Congress, Vienna, Austria
30. Breast Cancer Conference, Brussels, Belgium
31. European Breast Cancer Conference, Amsterdam, The Netherlands
Relevant Societies and Associations:
1. The Association of Bimolecular Resource Facilities (ABRF), Bethesda, MD, USA
2. American Society of Gene and Cell Therapy, Milwaukee, Wisconsin, USA
3. American Society for Microbiology, USA
4. RNA Society - Maryland, USA
5. Society for Industrial Microbiology and Biotechnology, Fairfax, Virginia, USA
6. Federation of American Societies for Experimental Biology (FASEB), Maryland, USA
7. BioFlorida- Life Science Community
8. European Society of Human Genetics, Vienna, Austria
9. European Society for Medical Oncology
10. European Society of Gynaecological Oncology
11. EuroPharm Forum
12. Friends of Cancer Research
13. American Cancer Society
14. National Cancer Institute
15. German Cancer Aid
16. Cancer Council Australia
17. Edinburgh Cancer Research Centre
18. World Cancer Research Fund, UK
Companies:
1. Affymetrix - Santa Clara, California USA
2. Roche NimbleGen Inc. Madison, Wisconsin, United States
3. SciGene Sunnyvale, California, United States\
4. Arrayit Corporation
5. DNAmicroarray California, USA
6. LC Sciences, Houston, TX, US
7. SeqWright Genomic Services (a unit of GE health care)
8. Roche
9. Novartis
10. Celgene
11. Bristol-Myers Squibb
12. Lilly
13. Takeda
14. Merck & Co.
15. AstraZeneca
16. Pfizer
17. Pharmacyclics
This page will be updated regularly.
This page was last updated on November 5, 2024
